Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis von Axelsson, M., Malmeström, C., Nilsson, S., Haghighi, S., Rosengren, L., Lycke, J.

Volltext

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis von Kuhle, J., Malmeström, C., Axelsson, M., Plattner, K., Yaldizli, Ö., Derfuss, T., Giovannoni, G., Kappos, L., Lycke, J.

Volltext

NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS von Novakova, L., Axelsson, M., Malmeström, C., Zetterberg, H., Blennow, K., Svenningsson, A., Lycke, J.

Volltext

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs von Tedeholm, H, Lycke, J, Skoog, B, Lisovskaja, V, Hillert, J, Dahle, C, Fagius, J, Fredrikson, S, Landtblom, A-M, Malmeström, C, Martin, C, Piehl, F, Runmarker, B, Stawiarz, L, Vrethem, M, Nerman, O, Andersen, O

Volltext

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis von Mattsson, N, Axelsson, M, Haghighi, S, Malmeström, C, Wu, G, Anckarsäter, R, Sankaranarayanan, S, Andreasson, U, Fredrikson, S, Gundersen, A, Johnsen, L, Fladby, T, Tarkowski, A, Trysberg, E, Wallin, A, Anckarsäter, H, Lycke, J, Andersen, O, Simon, AJ, Blennow, K, Zetterberg, H

Volltext

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles von Malmeström, C., Andersson, B.A., Haghighi, S., Lycke, J.

Volltext

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein von Novakova, Lenka, Zetterberg, Henrik, Sundström, Peter, Axelsson, Markus, Khademi, Mohsen, Gunnarsson, Martin, Malmeström, Clas, Svenningsson, Anders, Olsson, Tomas, Piehl, Fredrik, Blennow, Kaj, Lycke, Jan

Volltext

Inflammation-related plasma and CSF biomarkers for sclerosis von Huang, J, Khademi, M, Fugger, L, Lindhe, O, Novakova, L, Axelsson, M, Malmestrom, C, Constantinescu, C, Lycke, J, Piehl, F

Volltext

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS von MALMESTROM, C, HAGHIGHI, S, ROSENGREN, L, ANDERSEN, O, LYCKE, J

Volltext

Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study von Johnsson, M, Stenberg, YT, Farman, HH, Blennow, K, Zetterberg, H, Malmeström, C, Sandgren, S, Rosenstein, I, Lycke, J, Axelsson, M, Novakova, L

Volltext

Neurofilament light in serum for monitoring multiple sclerosis: A new quantitative tool for measuring disease activity and therapeutic response von Novakova, L., Zetterberg, H., Axelsson, M., Sundström, P., Khademi, M., Gunnarsson, Martin, Malmeström, C., Svenningsson, A., Olsson, T., Piehl, F., Blennow, K., Lycke, J.

Volltext

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients von Alping, Peter, Frisell, Thomas, Novakova, Lenka, Islam-Jakobsson, Protik, Salzer, Jonatan, Björck, Anna, Axelsson, Markus, Malmeström, Clas, Fink, Katharina, Lycke, Jan, Svenningsson, Anders, Piehl, Fredrik

Volltext

Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis von Novakova, Lenka, Axelsson, Markus, Khademi, Mohsen, Zetterberg, Henrik, Blennow, Kaj, Malmeström, Clas, Piehl, Fredrik, Olsson, Tomas, Lycke, Jan

Volltext

Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis von Novakova, Lenka, Axelsson, Markus, Khademi, Mohsen, Zetterberg, Henrik, Blennow, Kaj, Malmeström, Clas, Piehl, Fredrik, Olsson, Tomas, Lycke, Jan

Volltext

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab von Gunnarsson, Martin, Malmeström, Clas, Axelsson, Markus, Sundström, Peter, Dahle, Charlotte, Vrethem, Magnus, Olsson, Tomas, Piehl, Fredrik, Norgren, Niklas, Rosengren, Lars, Svenningsson, Anders, Lycke, Jan

Volltext

Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis von Constantinescu, R., Krýsl, D., Bergquist, F., Andrén, K., Malmeström, C., Asztély, F., Axelsson, M., Menachem, E. B., Blennow, K., Rosengren, L., Zetterberg, H.

Volltext

Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register‐based cohort study von O'Connor, Laura, Malmeström, Clas, Da Silva Rodrigues, Rui, Brauner, Susanna, Wikström, Anna‐Karin, Punga, Anna Rostedt

Volltext

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective surve... von Sandgren, Sofia, Novakova, Lenka, Axelsson, Markus, Amirbeagi, Firoozeh, Kockum, Ingrid, Olsson, Tomas, Malmestrom, Clas, Lycke, Jan

Volltext

The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies von Rabenstein, Monika, Thomas, Olivia G., Carlin, Giorgia, Khademi, Mohsen, Högelin, Klara Asplund, Malmeström, Clas, Axelsson, Markus, Brandt, Anne Frandsen, Gafvelin, Guro, Grönlund, Hans, Kockum, Ingrid, Piehl, Fredrik, Lycke, Jan, Olsson, Tomas, Hessa, Tara

Volltext

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study von Kuhle, J, Disanto, G, Dobson, R, Adiutori, R, Bianchi, L, Topping, J, Bestwick, JP, Meier, U-C, Marta, M, Costa, G Dalla, Runia, T, Evdoshenko, E, Lazareva, N, Thouvenot, E, Iaffaldano, P, Direnzo, V, Khademi, M, Piehl, F, Comabella, M, Sombekke, M, Killestein, J, Hegen, H, Rauch, S, D’Alfonso, S, Alvarez-Cermeño, JC, Kleinová, P, Horáková, D, Roesler, R, Lauda, F, Llufriu, S, Avsar, T, Uygunoglu, U, Altintas, A, Saip, S, Menge, T, Rajda, C, Bergamaschi, R, Moll, N, Khalil, M, Marignier, R, Dujmovic, I, Larsson, H, Malmestrom, C, Scarpini, E, Fenoglio, C, Wergeland, S, Laroni, A, Annibali, V, Romano, S, Martínez, AD, Carra, A, Salvetti, M, Uccelli, A, Torkildsen, Ø, Myhr, KM, Galimberti, D, Rejdak, K, Lycke, J, Frederiksen, JL, Drulovic, J, Confavreux, C, Brassat, D, Enzinger, C, Fuchs, S, Bosca, I, Pelletier, J, Picard, C, Colombo, E, Franciotta, D, Derfuss, T, Lindberg, RLP, Yaldizli, Ö, Vécsei, L, Kieseier, BC, Hartung, HP, Villoslada, P, Siva, A, Saiz, A, Tumani, H, Havrdová, E, Villar, LM, Leone, M, Barizzone, N, Deisenhammer, F, Teunissen, C, Montalban, X, Tintoré, M, Olsson, T, Trojano, M, Lehmann, S, Castelnovo, G, Lapin, S, Hintzen, R, Kappos, L, Furlan, R, Martinelli, V, Comi, G, Ramagopalan, SV, Giovannoni, G

Volltext